Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop universal influenza vaccines that induce a more robust immune response against various virus subtypes, including both human and avian strains.
https://www.sciencedaily.com/r....eleases/2025/05/2505

Engineering an antibody against flu with sticky staying power Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the broad binding capacity of a more general immune system defender.
https://www.sciencedaily.com/r....eleases/2025/05/2505

Study reveals gaps in flu treatment for high-risk adults A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found that only slightly more than half of these patients received antiviral prescriptions, and of those, only 80 percent were filled. This gap in treatment could increase the risk of severe flu complications, particularly for older adults and those with underlying conditions.
https://www.sciencedaily.com/r....eleases/2025/04/2504

Americans don't think bird flu is a threat, study suggests A team led by researchers say public ignorance and apathy towards bird flu (highly pathogenic avian influenza, or HPAI) could pose a serious obstacle to containing the virus and preventing a larger-scale public health crisis.
https://www.sciencedaily.com/r....eleases/2025/04/2504

Nasal spray H5N1 avian influenza vaccine developed Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform enabled the rapid development of a nasal spray vaccine in collaboration with mainland China's Wantai BioPharm. After completing Phase 1-3 clinical trials, it was approved in 2022 as the world's first nasal spray COVID-19 vaccine.
https://www.sciencedaily.com/r....eleases/2025/04/2504